Amneal Pharmaceuticals announced that its Co-CEO and President, Chirag Patel, will present at the Goldman Sachs 47th Annual Global Healthcare Conference from June 8-10, 2026, in Miami. The presentation is scheduled for June 9 at 8:40 AM EDT and will be webcast live. Amneal is a global biopharmaceutical company focused on affordable and innovative medicines, with a diverse portfolio including generics, specialty, and biosimilar drugs. This event provides Amneal an opportunity to showcase its growth and strategy to investors and industry stakeholders.
SL BIO Ltd. has finalized its merger with Horizon Space Acquisition II and will begin trading on Nasdaq under the ticker SLBT. The deal, valuing SL BIO at about $5.57 billion and including $7.8 million in PIPE financing, provides capital to develop i...
The Carlyle Group has acquired South Korea's Chung Ho Group, a home and healthcare appliance rental platform, for $700 million, driven by inheritance tax issues and lack of heirs. Meanwhile, GoHealth, a digital health and Medicare insurance marketpla...
Abbott's board announced a quarterly dividend of 63 cents per share, marking the company's 410th consecutive quarterly dividend since 1924. This consistent dividend payment underscores Abbott's long-standing commitment to returning value to sharehold...
A fire destroyed Medline's 1 million-square-foot medical equipment warehouse in Tracy, California, affecting about 4% of its U.S. warehouse space. The blaze caused inventory losses and disrupted operations, creating short-term margin pressure as the ...
SpaceX is choosing to focus on long-term growth rather than immediate profitability, similar to Amazon's approach in its early years. Experts say SpaceX could be profitable now if it reduced spending on projects like Starship and AI infrastructure, b...
